Last week’s JP Morgan Healthcare Conference made one thing clear: Healthcare innovation is alive, urgent, and deeply consequential.
From surgical robotics to AI-driven discovery, the industry is focused on technologies that improve outcomes while reducing cost and complexity. New platforms, expanded robotic applications, and advanced analytics are converging to reshape how care is delivered and how diseases are understood.
A major focus was spatial biology and proteomics, fields that help researchers see how cells and proteins behave in context and respond to treatment. These insights are essential to precision medicine, ensuring patients receive therapies that are more effective and better tolerated.
The technologies our teams are building will help future patients and physicians make better, more confident decisions.
The future of healthcare is being built now, and we are proud to play a critical role in enabling it.